Evidence map›Paper›PMID 42096001›Full record

ArticleCerebellum (London, England)2026

Identification of FGF14 GAA Expansions in Polish Patients with Undiagnosed Cerebellar Ataxia - A Preliminary Study.

Marta Matlawska, Karolina Ziora-Jakutowicz, Marie-Josee Dicaire, Joanna Pera, David Pellerin, Bernard Brais, Pablo Iruzubieta, Ewelina Elert-Dobkowska, Anna Sulek

Abstract read
In one paragraph

Article in Cerebellum (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Marta MatlawskaDepartment of Genetics, Institute of Psychiatry and Neurology, Sobieskiego 9 , 02-957, Warsaw, Poland. mmatlawska@ipin.edu.pl.ORCID http://orcid.org/0000-0003-4310-5091
Karolina Ziora-JakutowiczDepartment of Genetics, Institute of Psychiatry and Neurology, Sobieskiego 9 , 02-957, Warsaw, Poland.
Marie-Josee DicaireDepartment of Neurology and Neurosurgery, Montreal Neurological Institute- Hospital, McGill University, Montreal, Québec, Canada.
Joanna PeraDepartment of Neurology, Jagiellonian University Medical College, Krakow, Poland.
David PellerinDepartment of Neurology and Neurosurgery, Montreal Neurological Institute- Hospital, McGill University, Montreal, Québec, Canada.
Bernard BraisDepartment of Neurology and Neurosurgery, Montreal Neurological Institute- Hospital, McGill University, Montreal, Québec, Canada.
Pablo IruzubietaDepartment of Neurology and Neurosurgery, Montreal Neurological Institute- Hospital, McGill University, Montreal, Québec, Canada.
Ewelina Elert-DobkowskaDepartment of Genetics, Institute of Psychiatry and Neurology, Sobieskiego 9 , 02-957, Warsaw, Poland.
Anna SulekFaculty of Medicine, Lazarski University, Warsaw, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Spinocerebellar ataxia type 27B (SCA27B), caused by an intronic GAA repeat expansion in the FGF14 gene, has recently emerged as a major cause of late-onset cerebellar ataxia (LOCA). Its prevalence and clinical profile in Central and Eastern Europe remain largely unknown. To determine the frequency and phenotypic characteristics of FGF14 GAA·TTC repeat expansions, a large cohort of Polish patients with undiagnosed adult-onset cerebellar ataxia was investigated. We retrospectively analyzed 701 patients (age of onset ≥ 25 years) with adult-onset cerebellar ataxia of unknown etiology, previously tested negative for SCA1, SCA2, SCA3, SCA8, and RFC1 expansions. GAA·TTC repeat lengths were assessed using long-range and repeat-primed PCR. Expansions ≥ 250 repeats were classified as pathogenic. Clinical and MRI data were evaluated where available. A control group of 66 neurologically healthy individuals was also screened. Pathogenic FGF14 expansions (≥ 250 repeats) were identified in 4.4% (31/701) of patients, including 23 with fully penetrant (≥ 300) and 8 with incompletely penetrant (250-299) alleles. No pathogenic expansions were found in controls. The mean age of onset was 49.8 years. Common symptoms included balance and gait disturbances, cerebellar syndrome, and episodic features such as diplopia. Cerebellar atrophy was present in 45% of patients with available MRI. No significant correlation between repeat length and age of onset was observed. Our findings confirm that FGF14 repeat expansions are an underrecognized cause of LOCA in Poland and support their inclusion in standard genetic testing for adult-onset ataxias. Further studies are warranted to better define penetrance and genotype-phenotype correlations.

Indexed as

Cerebellar AtaxiaFibroblast Growth FactorsTrinucleotide Repeat ExpansionAdultAgedAge of OnsetFemaleHumansMaleMiddle AgedPolandRetrospective StudiesSpinocerebellar Degenerationsfibroblast growth factor 14Fibroblast Growth FactorsFGF14 expansionNeurodegenerative disordersSCA27BSpinocerebellar ataxia

Identifiers

PMID42096001
PMCPMC13152904

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.